Diary - News
All news Nosopharm joins ENABLE project
Nosopharm, a biotechnology company specialized in the research and development of new antibacterial molecules, announced it has been selected to join ENABLE (European Gram-negative Antibacterial Engine), a project working to advance the development of potential antibiotics against multidrug resistant Gram-negative infections.